NO2706982T3 - - Google Patents

Info

Publication number
NO2706982T3
NO2706982T3 NO12721507A NO12721507A NO2706982T3 NO 2706982 T3 NO2706982 T3 NO 2706982T3 NO 12721507 A NO12721507 A NO 12721507A NO 12721507 A NO12721507 A NO 12721507A NO 2706982 T3 NO2706982 T3 NO 2706982T3
Authority
NO
Norway
Application number
NO12721507A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44658496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2706982(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2706982T3 publication Critical patent/NO2706982T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO12721507A 2011-05-13 2012-05-11 NO2706982T3 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11166076 2011-05-13
PCT/EP2012/058792 WO2012156317A2 (en) 2011-05-13 2012-05-11 Intranasal pharmaceutical dosage forms comprising naloxone
EP12721507.7A EP2706982B2 (en) 2011-05-13 2012-05-11 Intranasal pharmaceutical dosage forms comprising naloxone

Publications (1)

Publication Number Publication Date
NO2706982T3 true NO2706982T3 (no) 2018-06-02

Family

ID=44658496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12721507A NO2706982T3 (no) 2011-05-13 2012-05-11

Country Status (36)

Country Link
US (7) US20150018379A1 (no)
EP (2) EP2706982B2 (no)
JP (3) JP6110367B2 (no)
KR (2) KR101873174B1 (no)
CN (2) CN107260672A (no)
AR (1) AR086391A1 (no)
AT (1) AT16553U1 (no)
AU (2) AU2012257785B2 (no)
BR (1) BR112013029126A2 (no)
CA (1) CA2835940C (no)
CO (1) CO6821959A2 (no)
CY (1) CY1120399T1 (no)
DE (1) DE202012013606U1 (no)
DK (2) DK2706982T4 (no)
ES (1) ES2661838T5 (no)
HK (1) HK1255428A1 (no)
HR (1) HRP20180233T1 (no)
HU (1) HUE036465T2 (no)
IL (1) IL229409B (no)
LT (1) LT2706982T (no)
ME (1) ME02958B (no)
MX (1) MX354249B (no)
MY (1) MY194947A (no)
NO (1) NO2706982T3 (no)
PH (1) PH12016501342A1 (no)
PL (1) PL2706982T3 (no)
PT (1) PT2706982T (no)
RS (1) RS57054B1 (no)
RU (2) RU2657441C1 (no)
SG (1) SG194927A1 (no)
SI (1) SI2706982T1 (no)
TR (1) TR201802716T4 (no)
TW (1) TWI486161B (no)
UA (1) UA110974C2 (no)
WO (1) WO2012156317A2 (no)
ZA (1) ZA201308280B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US20150018379A1 (en) * 2011-05-13 2015-01-15 Euro-Celtique S.A. Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
EP3082816B1 (en) * 2013-12-20 2019-03-20 Indivior UK Limited Intranasal naloxone compositions and methods of making and using same
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
CN110755372A (zh) 2014-03-14 2020-02-07 欧皮安特制药有限公司 适于经鼻递送药物产品、用于鼻内给予的药用组合物及其用途
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US11135155B2 (en) * 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
CA2954637A1 (en) * 2014-07-09 2016-01-14 Opiant Pharmaceuticals, Inc. Co-packaged drug products
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
WO2017011326A1 (en) * 2015-07-10 2017-01-19 Sanjay Gupta Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene
CA2950687C (en) * 2015-09-17 2023-02-28 Adapt Pharma Limited Nasal drug products and methods of their use
JP2019520361A (ja) * 2016-06-24 2019-07-18 オーピアント ファーマシューティカルズ， インコーポレイテッド アルコール使用障害の処置のための組成物、装置、及び、方法
CA3033897C (en) * 2016-08-17 2024-03-26 Insys Development Company, Inc. Liquid naloxone spray
WO2020198327A1 (en) * 2019-03-26 2020-10-01 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
CN114144224A (zh) 2019-03-26 2022-03-04 保科特纳洛克斯恩公司 药物合成物输送器械和方法
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
WO2021222545A1 (en) * 2020-04-29 2021-11-04 The Texas A&M University System Naloxone nanoparticle compositions and methods thereof
EP3962455B1 (en) 2020-05-18 2022-08-31 Orexo AB New pharmaceutical composition for drug delivery
US11278709B1 (en) 2021-03-12 2022-03-22 Pocket Naloxone Corp. Drug delivery device and methods for using same
EP4236921A1 (en) 2021-11-25 2023-09-06 Orexo AB Pharmaceutical composition comprising adrenaline

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
GB9202464D0 (en) 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
US5866154A (en) * 1994-10-07 1999-02-02 The Dupont Merck Pharmaceutical Company Stabilized naloxone formulations
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
EP1183027A4 (en) 1999-06-16 2003-02-05 Nastech Pharmaceutical Co PHARMACEUTICAL FORMULATIONS AND METHODS COMPRISING INTRA-NASAL DELIVERY MORPHINE
GB9924797D0 (en) 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US6284765B1 (en) 2000-04-27 2001-09-04 The University Of North Texas Health Science Center At Fort Worth (+) naloxone and epinephrine combination therapy
WO2002011778A1 (en) * 2000-05-10 2002-02-14 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
SI1307194T2 (sl) * 2000-07-31 2011-07-29 Nycomed Danmark Aps Sestavek fentanila za nazalno dejanje
DE10064219B9 (de) 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
US7666876B2 (en) 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
EP1535615A4 (en) 2002-07-11 2010-03-31 Taiho Pharmaceutical Co Ltd COMPOSITION FOR THE NASAL ABSORPTION
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
CN1575795A (zh) * 2003-06-25 2005-02-09 中国人民解放军军事医学科学院毒物药物研究所 盐酸纳洛酮鼻腔喷雾剂
GB2403711A (en) * 2003-07-07 2005-01-12 Gw Pharma Ltd Drug dispenser with controlled access
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
CN1726915B (zh) * 2004-07-27 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 盐酸纳洛酮鼻腔给药系统或组合物及其制备方法
JP4922762B2 (ja) 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
JP2008521024A (ja) * 2004-11-09 2008-06-19 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 空間光変調装置のアレイ及び空間光変調装置の製造方法
AU2005322305B2 (en) * 2004-12-23 2010-09-16 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac
US8911751B2 (en) 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US20070212307A1 (en) * 2006-02-10 2007-09-13 Daniel Wermeling Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
RU2344822C2 (ru) * 2006-04-05 2009-01-27 Алексей Валентинович Надеждин Способ лечения героиновой наркомании
JP5415769B2 (ja) 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
AU2008206105B2 (en) * 2007-01-19 2014-04-03 Hananja Ehf Methods and compositions for the delivery of a therapeutic agent
WO2009040595A1 (en) 2007-09-28 2009-04-02 Wockhardt Research Centre Multi-dose pharmaceutical composition of analgesic for nasal administration
US20150018379A1 (en) * 2011-05-13 2015-01-15 Euro-Celtique S.A. Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
EP3082816B1 (en) 2013-12-20 2019-03-20 Indivior UK Limited Intranasal naloxone compositions and methods of making and using same
CN110755372A (zh) 2014-03-14 2020-02-07 欧皮安特制药有限公司 适于经鼻递送药物产品、用于鼻内给予的药用组合物及其用途
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray

Also Published As

Publication number Publication date
KR20170010078A (ko) 2017-01-25
AU2012257785A1 (en) 2013-11-28
ES2661838T3 (es) 2018-04-04
WO2012156317A3 (en) 2013-05-10
AR086391A1 (es) 2013-12-11
RS57054B1 (sr) 2018-05-31
SI2706982T1 (en) 2018-05-31
DE202012013606U1 (de) 2018-04-18
CY1120399T1 (el) 2019-07-10
BR112013029126A2 (pt) 2017-02-07
UA110974C2 (uk) 2016-03-10
US20150126540A1 (en) 2015-05-07
IL229409B (en) 2020-10-29
ES2661838T5 (es) 2021-11-18
US20170304192A1 (en) 2017-10-26
AU2016204880B2 (en) 2017-11-23
US20210338574A1 (en) 2021-11-04
HUE036465T2 (hu) 2018-07-30
US11806428B2 (en) 2023-11-07
US20150018379A1 (en) 2015-01-15
RU2657441C1 (ru) 2018-06-13
TW201311244A (zh) 2013-03-16
EP3320893A1 (en) 2018-05-16
CA2835940A1 (en) 2012-11-22
KR101873174B1 (ko) 2018-06-29
US20170231904A1 (en) 2017-08-17
LT2706982T (lt) 2018-05-25
MY194947A (en) 2022-12-27
TR201802716T4 (tr) 2018-03-21
CN107260672A (zh) 2017-10-20
MX2013013276A (es) 2014-08-07
NZ617442A (en) 2015-03-27
DK2706982T4 (da) 2021-05-10
HK1255428A1 (zh) 2019-08-16
JP6110367B2 (ja) 2017-04-05
CA2835940C (en) 2020-08-04
AU2016204880A1 (en) 2016-07-28
ME02958B (me) 2018-07-20
EP2706982B2 (en) 2021-03-10
NZ705933A (en) 2016-07-29
KR20140007482A (ko) 2014-01-17
AT16553U1 (de) 2020-01-15
RU2587051C2 (ru) 2016-06-10
EP2706982B1 (en) 2018-01-03
IL229409A0 (en) 2014-01-30
CN103764119A (zh) 2014-04-30
EP2706982A2 (en) 2014-03-19
RU2013155479A (ru) 2015-06-20
DK201800034U1 (da) 2018-05-25
US20240082149A1 (en) 2024-03-14
AU2012257785B2 (en) 2016-04-14
PT2706982T (pt) 2018-03-08
TWI486161B (zh) 2015-06-01
SG194927A1 (en) 2013-12-30
JP2014513683A (ja) 2014-06-05
KR101698182B1 (ko) 2017-01-19
JP2016128453A (ja) 2016-07-14
ZA201308280B (en) 2014-07-30
MX354249B (es) 2018-02-20
JP2018150336A (ja) 2018-09-27
PH12016501342B1 (en) 2018-06-11
PH12016501342A1 (en) 2018-06-11
CO6821959A2 (es) 2013-12-31
DK2706982T3 (en) 2018-03-12
WO2012156317A2 (en) 2012-11-22
HRP20180233T1 (hr) 2018-06-01
US20190374464A1 (en) 2019-12-12
US11020343B2 (en) 2021-06-01
PL2706982T3 (pl) 2018-07-31

Similar Documents

Publication Publication Date Title
BR112013022641A2 (no)
BR112013031251A2 (no)
BR112013027245A2 (no)
BR112013026905A2 (no)
BR112013023185A2 (no)
BR112013022995A2 (no)
BR112013017670A2 (no)
BR112013023927A2 (no)
BR112013027830A2 (no)
BR112013024365A2 (no)
BR112013028733A2 (no)
BR112013027121A2 (no)
BR112013027452A2 (no)
BR112013031556A2 (no)
NO2706982T3 (no)
BR112013024588A2 (no)
BR112013032380A2 (no)
BR112013032377A2 (no)
BR112013032368A2 (no)
BR112013018949A2 (no)
BR112013027761A2 (no)
BR112013021637A2 (no)
BR112013027836A2 (no)
BR112013023266A2 (no)
BR112013032392A2 (no)